Descriptive case series of patients presenting with cancer of the prostate and their management at Kenyatta National Hospital, Nairobi

East African Medical Journal

Volumn 84, Issue 9 SUPPL., 2007, Pages

  Wasike, R W ^a   Magoha, G A O ^b  

^a AGA KHAN UNIVERSITY   (Kenya)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; HUMAN; KENYA; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PROSTATE TUMOR;

AGED; AGED, 80 AND OVER; HUMANS; KENYA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS;

EID: 36349026959     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Schally A. V., Comaru-Schally A.M., Plonowskl A. et al. Peptide analogs in therapy of prostate cancer. Prostate. 2000: 45:158-186.
2. Crawford E. D. Prostate cancer awareness week: September 22-28, 1997 CA. Cancer J. Clin. 1997: 47: 288-296.
3. Jemal A., Siegel R., Ward E., et al. Cancer Statistics 2007 CA. Cancer J. Clin. 2007; 57:43-66.
4. Sarma A. W. and Schuttenfield D. Prostate cancer incidence, mortality and survival trends in the United States 1981-2001. Semin. Urol. Oncol. 2002; 20:3-9.
5. Cooperberg M.R., Moul J.W. and Corrol P. R. The changing phase of prostate cancer. J. Clin. Oncol. 2005; 23:8146-8151.
6. Boyle P. and Ferlay J. Cancer incidence and mortality in Europe 2004. Ann. Oncol. 2005; 16: 481-488.
7. Marberger M. Current prostate cancer: 20 years later. BJU. Intern. 2007;100 (Suppl 2): 11-14.
8. Abrahamsson P. Active surveillance vs Radical prostatectomy. BJU Intern. 2007; 100 (Supppl 2): 26-28.
9. Albertson P. C., Fryback D. G., Storer B. E. et al. Studies in epidemiology of prostate cancer expanded sampling. Cancer Treatment Report. 1996; 156: 127-132.
10. Smith J. R., Freije D., Carlpten J.D. et al. Major susceptibility locus for prostate cancer on chromosome. Suggested by Genome. Wide Res. Sci 1996; 274(5291): 1371-1374.
11. Chodak G. W., Thisted R. A., Gerber G. S. et al. Results of conservative management of clinically localized disease of prostate cancer New. Engl. J. Med. 1994; 330: 242-248.
12. Akuku P.O. Carcinoma of the prostate: MMed. (Surgery) Dissertation University of Nairobi, 1987.
13. Debre B., Geraud M., Flam T. and Steg A. Epidemiology of prostate cancer. J. Int. Med. Res. 1990;18(Suppl 1): 3-7.
14. Angwafo F. F. Migration and prostate cancer: An international percepective. J. Natl. Med. Assoc. 1998; 90(II Suppl): ST20-723.
15. Angwafo F. F., Yomi J. and Mbakop A. Is cancer of the prostate rare in tropical black Africa? Case series from Center Hospitalizer et Universitaire and Hospital General de Younde fro1986-1990. Bull. Cancer Radiother. 1994; 81: 155-159.
16. Osegbe D. N. Prostate Cancer in Nigerians: Facts and non facts. J. Urol. 1997; 157: 1340-1343.
17. Magoha G. A. Management and survival in advanced prostate cancer in Nairobi. East Afr. Med. J. 2000; 77: 260-263.
18. Mohammed A. Z, Alhassan S. U., Edlno S. T. and Ochicha O. Histopathological review of prostatic diseases in Kano Nigeria. Niger. Postgrad. Med. J. 2003; 10: 1-5.
19. Ekwere P. D. and Egbe S. N. The changing pattern of prostate cancer in Nigerians: Current status in South Easter States. J. Natl. Med. Assoc. 2002: 94: 619-627.
20. Angwafo F.F., Zaher A., Befidi-Menguer et al. The National Health Survey Team for the National Epidemiology Board of Cameroon. High grade intra-epithelial neoplasia and prostate cancer in Dobombari Cameroon. Prostate Cancer Prostatic Dis. 2003; 6:34-38.
21. Gueye S. M., Zeigler-Johnson C.M., Friebel T., et al. Clinical characteristics of prostate cancer in African Americans, American whites and and Senegalese men. Urology. 2003; 61: 987-992.
22. The Vererans Administration Cooperative Urological Research Group. Treatment and survival of patients with cancer of the prostate. Surg. Gynaecol. Obstet. 1967; 124: 1011-1017.
23. Yawe K. T., Tahir M. B., and Nggada H. A. Prostate cancer in Maiduguri. West Afr. J. Med. 2006; 25: 298-300.
24. Jackson M. A., Kovi J. Heshmat M.Y., et al. Characterization of prostatic carcinoma among blacks: A comparison between a low-incidence area Ibadan Nigeria and high- incidence area Washington D.C. Prostate. 1980; 1: 185-205.
25. Walker A.R., Walker B. F., Isaacson C., Doodha M. I. and Segal I. Survival of black men with prostatic cancer in Soweto Johannesburg, South Africa. J. Urol. 1986; 135: 58-59.
26. Schally A. V. Lutenizing hormone releasing hormone analogs: Their impact on control of tumorigenesis. Peptides. 1999; 20: 1247-1262.
27. Homberg L., Bill-Axelson A., Helgensen F. et al. Scandinavian prostatic prostate cancer group study No. 4 A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. New Engl. J. Med 2002; 347: 781-789.
28. Rotkin I. D., Kirby S. R. et al. Studies in epidemiology of prostate cancer: Expanded sampling. Cancer Treat. Rep. 1977; 61: 173-180.